drugset / Trial / NCT05603598
LEAP2 on Postprandial Glucose Metabolism and Food Intake n Obese Males
RandomizedCrossoverDouble-blindBasic science
Summary
The study aims to delineate the effects of the naturally occurring peptide liver-enriched antimicrobial peptide 2 (LEAP-2) on postprandial glucose metabolism and food intake in obese volunteers. The overall objective is to investigate the physiological importance of LEAP-2 in obese subjects.
Timeline
- Start
- 2022-08-24
- Primary completion
- 2023-05-01
- Completion
- 2023-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LEAP2 | Peptide | — | Intravenous |